How many acquisitions has Gilead made so far?

Gilead has completed 21 acquisitions so far, with an average acquisition amount of $5.27B.

Which countries does Gilead usually acquire in?

Gilead has made acquisitions in 5 countries with the most activity in United States and Germany.

Which is Gilead's latest acquisition?

Gilead's most recent acquisition is Tubulis Technologies, a Developer of antibody-drug conjugates for the treatment of cancer, acquired in April 2026 for $3.15B.

Which sectors does Gilead target for acquisitions?

Most of Gilead's acquisitions are in Oncology (14) and Immunotherapy (9).

List of 21 Acquisitions by Gilead (Apr 2026)

Gilead has completed a total of 21 acquisitions, with peak activity in 2026 and 2020 (3 acquisitions each), and 2017 (2 acquisitions). Acquisitions have been made across 5 countries, notably in United States (16 acquisitions), Germany (2 acquisitions), and United Kingdom (1 acquisition). Acquisitions span 10 sectors, concentrating on Oncology (14 acquisitions), Immunotherapy (9 acquisitions), and Infectious Diseases (3 acquisitions). Between 2020 and 2025, an average of 0.6 acquisitions were completed annually. So far this calendar year, 3 acquisitions have been completed. The most recent acquisition was Tubulis Technologies, finalized in April 2026 for $3.15B. Founded in 2015 and based in Munich, Tubulis Technologies specializes in developing antibody-drug conjugates for cancer treatment.

Here's the year on year acquisition history of Gilead:

Number of Total Acquisitions

Year	# Acquisitions
2026	3
2024	1
2023	1
2022	1
2020	3
2017	2
2015	1
2012	1
2011	2
2010	2
2009	1
2006	2
2002	1

View all Acquisitions by Gilead

Recent acquisitions by Gilead

Gilead's most recent acquisition - Tubulis Technologies is a Developer of antibody-drug conjugates for the treatment of cancer, founded in 2015 and located in Munich. Gilead acquired it in April 2026 for a price of $3.15B.

Here is the list of all acquisitions by Gilead sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Apr 08, 2026	Tubulis Technologies	$3.15B	GreenGate	21	316
Mar 23, 2026	Ouro Medicines	Undisclosed	-	53	346
Feb 23, 2026	Arcellx	$7.8B	Bank of America, Morgan Stanley ... and 3 more	27	930
Feb 12, 2024	CymaBay Therapeutics	$4.3B	Guggenheim Securities, Lazard ... and 4 more	81	810
May 01, 2023	XinThera	Undisclosed	-	71	905